These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30507437)

  • 1. Defining priority medical devices for cancer management: a WHO initiative.
    Velazquez Berumen A; Jimenez Moyao G; Rodriguez NM; Ilbawi AM; Migliore A; Shulman LN
    Lancet Oncol; 2018 Dec; 19(12):e709-e719. PubMed ID: 30507437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers.
    Pearson AD; Heenen D; Kearns PR; Goeres A; Marshall LV; Blanc P; Vassal G
    Lancet Oncol; 2018 Mar; 19(3):285-287. PubMed ID: 29508745
    [No Abstract]   [Full Text] [Related]  

  • 3. Core elements of national cancer control plans: a tool to support plan development and review.
    Oar A; Moraes FY; Romero Y; Ilbawi A; Yap ML
    Lancet Oncol; 2019 Nov; 20(11):e645-e652. PubMed ID: 31674323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing an independent Palestinian cancer care capacity.
    Gil Z; Atrash F; Za'aroura S; Billan S; Nammour W
    Lancet Oncol; 2019 Nov; 20(11):1485-1486. PubMed ID: 31674309
    [No Abstract]   [Full Text] [Related]  

  • 6. UK Government urged to recognise post-COVID-19 cancer backlog.
    Wilkinson E
    Lancet Oncol; 2021 Jul; 22(7):910. PubMed ID: 34090554
    [No Abstract]   [Full Text] [Related]  

  • 7. National cancer control plans: a global analysis.
    Romero Y; Trapani D; Johnson S; Tittenbrun Z; Given L; Hohman K; Stevens L; Torode JS; Boniol M; Ilbawi AM
    Lancet Oncol; 2018 Oct; 19(10):e546-e555. PubMed ID: 30268693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World Health Organization List of Priority Medical Devices for Cancer Management to Promote Universal Coverage.
    Ilbawi AM; Velazquez-Berumen A
    Clin Lab Med; 2018 Mar; 38(1):151-160. PubMed ID: 29412879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No impact of English national cancer policies on survival.
    Burki TK
    Lancet Oncol; 2018 May; 19(5):e230. PubMed ID: 29576416
    [No Abstract]   [Full Text] [Related]  

  • 10. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
    O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
    Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative.
    Extermann M; Brain E; Canin B; Cherian MN; Cheung KL; de Glas N; Devi B; Hamaker M; Kanesvaran R; Karnakis T; Kenis C; Musolino N; O'Donovan A; Soto-Perez-de-Celis E; Steer C; Wildiers H;
    Lancet Oncol; 2021 Jan; 22(1):e29-e36. PubMed ID: 33387502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed US Government budget cuts would 'devastate' cancer research.
    Furlow B
    Lancet Oncol; 2017 May; 18(5):577. PubMed ID: 28343979
    [No Abstract]   [Full Text] [Related]  

  • 14. Generating Global Priority for Addressing Rheumatic Heart Disease: A Qualitative Policy Analysis.
    Shawar YR; Shiffman J
    J Am Heart Assoc; 2020 Apr; 9(8):e014800. PubMed ID: 32308101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Political priority and pathways to scale-up of childhood cancer care in five nations.
    Denburg AE; Ramirez A; Pavuluri S; McCann E; Shah S; Alcasabas T; Antillon F; Arora R; Fuentes-Alabi S; Renner L; Lam C; Friedrich P; Maser B; Force L; Galindo CR; Atun R
    PLoS One; 2019; 14(8):e0221292. PubMed ID: 31425526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO priority list of medical devices for cancer management.
    Mayor S
    Lancet Oncol; 2017 Jul; 18(7):856. PubMed ID: 28552214
    [No Abstract]   [Full Text] [Related]  

  • 17. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shooting for the moon, and the stars?
    The Lancet Oncology
    Lancet Oncol; 2016 Aug; 17(8):1019. PubMed ID: 27511144
    [No Abstract]   [Full Text] [Related]  

  • 19. How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?
    Schleicher SM; Wood NM; Lee S; Feeley TW
    Oncology (Williston Park); 2016 May; 30(5):468-74. PubMed ID: 27188679
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.